ARCHIVES

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

This article is from The Cancer Letter archive.

Vol. 24 No. 22 | June 5, 1998

Download PDF Visit The Full Archive

Related Articles

President’s Cancer Panel: NCI’s Approach “Paying Off,” Thompson Tells Cancer Panel

June 1, 2001

Genentech’s Ferrara Selected for GM Award.

June 23, 2006

LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita

March 21, 1986

Minority Accrual Low In Prevention Trials; NCI Plans Programs To Boost enrollment

February 2, 1996

NCAB Committee Urged to Seek Surgical Oncology Certification

June 14, 1985

Conversation with The Cancer Letter: Pat White: NIH Funding “Our Only Concern”

September 26, 2014